Georgiamune

Georgiamune Inc. is a clinical stage biotechnology company focused on reprogramming immune signaling pathways to fight cancer and autoimmune diseases. The company has developed a pipeline of first-in-class immunotherapies aimed at restoring immune balance and overcoming therapy resistance.